Scottish company secures £4.2m to advance 3D-printed micro-tumour tech
Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.
Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.
What's Your Reaction?
